Financials

  • Market Capitalization 43.27 M
  • Employee 17
  • Founded 2018
  • CEO N/A
  • Website www.instilbio.com
  • Headquarter New York, United States
  • FIGI BBG00ZGYN521
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.03
Relación precio/flujo de caja
151.55

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4190
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.99 USD+1.02%+6.45%+2.06%-38.51%48.11 M USD
4202
APLM
Apollomics Inc. - Class A Ordinary Shares
21.17 USD-1.53%-7.55%-8.67%+15.05%46.49 M USD
4228
TVGN
Tevogen Bio Holdings Inc. - Common Stock
6.57 USD-1.65%+0.77%-7.72%+825.35%42.78 M USD
4238
GRCE
Grace Therapeutics, Inc. - Common Stock
2.00 USD-0.99%-5.66%-9.50%-49.75%42.07 M USD

Noticias